Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
41 /100
MEDIUM RISK
Score updated Oct 13, 2026

LRMR — Larimar Therapeutics, Inc. Dilution Risk Tracker

Track LRMR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LRMR — Get alerts when the score changes →

As of October 13, 2026, Larimar Therapeutics, Inc. (LRMR) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. Larimar Therapeutics, Inc. has a market capitalization of $277.37M, 103.88M shares outstanding, 163 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $100.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $100M remaining capacity
🔔 Track LRMR — Get forecast alerts →

Market Data

Market Cap$277.37M
Shares Outstanding103.88M
Float59.99M
Cash$92.69M
Debt$14.54M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore41/100DilutionWatch score record
Shares Outstanding103.88MVerified float table or market cache
Public Float59.99MVerified float table or market cache
Market Cap$277.37MMarket data cache
Cash Runway12.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$100.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 17.1% shares (2026Q1 vs prior)
163 institutional holders · 95.17M shares
#1 DEERFIELD MANAGEMENT COMPANY, L.P. 35.61M shares
#2 Blue Owl Capital Holdings LP 7.12M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 5.73M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest15.37M
Days to Cover8.7
% of Float25.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2023-11-14
xbrl XBRL CONVERTIBLE 2015-03-25
4 INSIDER TRANSACTION 2026-03-02
4 INSIDER TRANSACTION 2026-03-02
4 INSIDER TRANSACTION 2026-03-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LRMR Dilution Snapshot

Larimar Therapeutics, Inc. (LRMR) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LRMR's DilutionScore is currently 41/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 31/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202641/100MEDIUM53 days
Aug 14 – Aug 21, 202631/100MEDIUM7 days
Jul 17 – Aug 13, 202628/100MEDIUM28 days
Jul 16, 202627/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LRMR shares outstanding have increased 25.0% from 83.09M (Mar 2026) to 103.88M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 17, 2026103.88M59.99M▼ 0.49%
May 10, 2026103.88M60.29M▲ 0.16%
May 04, 2026103.88M60.19M▲ 9.47%
Apr 21, 2026103.88M54.99M▼ 0.02%
Mar 23, 2026103.59M54.99M▼ 11.43%
Mar 22, 2026103.59M62.09M▲ 25.02%
Mar 20, 2026103.59M49.67M▼ 2.92%
Mar 12, 2026103.59M51.16M▼ 0.36%
Mar 05, 202683.09M51.34M▼ 7.14%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LRMR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LRMR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LRMR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LRMR
LRMR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.